Business Trip
Podcast autorstwa Greg Kubin & Matias Serebrinsky - Czwartki
59 Odcinki
-
What's wrong with US healthcare and how startups can fix it, with Justin Mares
Opublikowany: 17.04.2025 -
Frontier investable areas in brain health with PsyMed Ventures
Opublikowany: 25.02.2025 -
Temporal Interference: The Future of Brain Stimulation with Nir Grossman
Opublikowany: 30.01.2025 -
The State of Autism Part 2 with James Adams of Gut-Brain-Axis Therapeutics Inc.
Opublikowany: 26.12.2024 -
The State of Autism Part 1 with Elizabeth Horn of 2m Foundation
Opublikowany: 12.12.2024 -
Genetic Medicine for Brain Health with Dana Watt of Breakout Ventures
Opublikowany: 14.11.2024 -
Transcranial Focused Ultrasound for Mental Health with Jay Sanguinetti of Sanmai
Opublikowany: 5.09.2024 -
Navigating FDA clinical trials in Neurotech with Tim Marjenin
Opublikowany: 23.08.2024 -
Environmental Toxins and Mental Health with Gurdane Bhutani
Opublikowany: 18.07.2024 -
FDA advisors say no to MDMA. What’s the impact? With Josh Hardman
Opublikowany: 21.06.2024 -
Investing in New Frontiers of Mental Health (Live at SXSW)
Opublikowany: 7.05.2024 -
Comparing Psychedelic Compounds in Therapy (Live Panel at Battery SF)
Opublikowany: 9.04.2024 -
What Payers Want with Lili Brillstein
Opublikowany: 14.03.2024 -
Decoding the Brain with Ed Boyden
Opublikowany: 22.02.2024 -
5-MeO-DMT in mental healthcare with Steve Rio
Opublikowany: 25.01.2024 -
Tom Insel: Startups, AI, Psychedelics, and SSRIs
Opublikowany: 15.12.2023 -
Food as Medicine for Mental Health: Drew Ramsey
Opublikowany: 30.11.2023 -
Ketogenic Diet for Brain Health: Jan Baszucki
Opublikowany: 16.11.2023 -
Investing in Neurotech 101: Alex Morgan of Khosla Ventures
Opublikowany: 2.11.2023 -
All you need is d̶r̶u̶g̶s̶ energy: Motif Neurotech's Implants for Depression
Opublikowany: 20.10.2023
Business Trip tells the story of businesses at the frontier of mental health and brain health. Each episode features founders, investors, and researchers in psychedelics, neurotechnology, metabolic psychiatry, digital therapeutics, and more.
